Amgen | سود ناخالص در فروش



Gross Profit On Sales تغییر دادن تاریخ
AbbVie USD 9.34B 1.36B 2025-03
Agios Pharmaceuticals USD 10.75M 3.11M 2025-06
ALKERMES USD 257.77M 462K 2025-06
Amgen USD 5.54B 430M 2025-03
Biogen USD 2.04B 238.8M 2025-06
BioMarin Pharmaceutical USD 670.47M 76.89M 2025-06
Bristol-Myers Squibb USD 8.9B 714M 2025-06
Eli Lilly USD 10.5B 624.7M 2025-03
Exelixis USD 548.79M 12.52M 2025-06
Genmab DKK 673M 5.43B 2025-03
Gilead Sciences USD 5.58B 453M 2025-06
GlaxoSmithKline GBP 5.82B 229M 2025-06
Glaxosmithkline GBP 5.6B 94M 2024-12
Incyte USD 1.14B 151.67M 2025-06
Ionis Pharmaceuticals USD 448M 317.85M 2025-06
J&J USD 14.6B 816M 2025-03
Merck USD 12.99B 224M 2025-06
Moderna USD 18M 1000K 2025-06
Neurocrine Biosciences USD 676.2M 112.8M 2025-06
Novartis USD 11.51B 1.12B 2025-06
Novartis USD 10.24B 313M 2024-12
Pfizer USD 11.12B 987M 2025-03
PTC Therapeutics USD 163.39M 999.84M 2025-06
Regeneron Pharmaceuticals USD 3.15B 581M 2025-06
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.74B 26M 2025-06
Sarepta Therapeutics USD 457.87M 149.43M 2025-06
Takeda JPY 722.01B 50.69B 2025-06
Teva Pharmaceutical Industries USD 2.1B 188M 2025-06
Ultragenyx Pharmaceutical USD 143.49M 32.86M 2025-06
Vertex Pharmaceuticals USD 2.56B 150M 2025-06


Amgen سود ناخالص در فروش - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Aug 2025.